ADELE HARRISON: Open Payments
NPI 1881052967 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 57 payments from 16 companies in 2025. Trend: 2023 $972 · 2024 $911 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 33 | $265 |
| UROGEN PHARMA, INC. | 2 | $180 |
| Antares Pharma, Inc. | 4 | $72 |
| Janssen Biotech, Inc. | 3 | $55 |
| PFIZER INC. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| ABBVIE INC. | 2 | $31 |
| IMMUNITYBIO, INC. | 1 | $31 |
| ACCORD HEALTHCARE, INC. | 1 | $27 |
| Boston Scientific Corporation | 1 | $26 |
Products named: ORGOVYX, JELMYTO, XYOSTED, ERLEADA, XTANDI, KEYTRUDA, ANKTIVA, Camcevi.
Industry payments across NE — which companies pay providers there.
